Doing the right thing for people & planet
Doing the right thing for people & planet
At Arcera, we are united by our bold ambition to be a catalyst for change; proudly progressing the way the world heals, thrives and evolves.
Our work is driven by a sense of care, bringing together the most advanced science, technology and people to innovate smarter health and wellbeing solutions, so patients can live longer, healthier lives. Because when we work together with open minds, we can achieve greater, lasting impact.
We don’t just adapt to the future; we shape it, building a path for progress that opens up new worlds of life sciences. Creating a better tomorrow for today’s patients and for generations to come.
We are committed to protecting the environment through responsible operations, efficient use of resources, and a clear path towards further decarbonization.
The environmental initiatives we identified in our Double Materiality Assessment focused on two priority areas.
We continuously aim to reduce greenhouse gas emissions.
We continue to assess energy performance across our manufacturing sites, to identify and implement the most effective actions to reduce Scope 1 and 2 emissions. We are also measuring and laying the groundwork for managing Scope 3 emissions associated with our logistics.
Digitalization and automation are helping us streamline IT systems, optimize the use of cloud computing, and increase efficiency in data storage and distribution.
We are increasing our energy efficiency and use of renewable energy.
By improving how we operate today, we are building a more efficient, responsible future for our business and generations to come.
0 tCO2e
Gross Scope 1 and 2 emissions
0MWh
Total energy consumption by Arcera TechOps sites
0%
Priority suppliers required to sign up to our Third Party Code
We working to reduce our environmental impacts through responsible waste and water management.
Our waste management program objectives are:
As a member of the Pharmaceutical Supply Chain Initiative (PSCI), we work to identify opportunities in our supply chain to reduce our environmental footprint.
Every action counts, from recycling and reducing waste to protecting water resources and local environments.
ISO 14001
At our manufacturing sites in Egypt, Türkiye, South Africa, and Ukraine
0kg
Total waste recycled
* Estonia, Switzerland, Ukraine, South Africa.
We aim to deliver positive outcomes for our employees, partners, suppliers, and customers.
Our relationships are based on integrity, respect, and trust. These values shape our business strategy, guide our future growth ambitions, and make Arcera the partner of choice for many organizations around the world.
Our People & Culture strategy is built on eight guiding principles:
We continue to strengthen employee wellbeing through initiatives supporting mental and physical health, workplace safety, learning and development, career growth and community engagement.
By supporting our people, we aim to strengthen engagement and build a positive culture.
0
Employees at the end of 2025
(incl. 715 new employees)
0%
Voluntary turnover rate in 2025
Our culture is shaped by cross-regional teamwork and interdisciplinary cooperation. That is why diversity, equity and inclusion are core principles embedded within our our Code of Ethics, which is the main policy that guides our conduct and decision-making across all operations.
Our priorities are:
We do not tolerate discrimination in any form.Our recruitment and people processes are supported by standard operating procedures that ensure fairness and compliance with our non-discrimination principles.
0%
Female employees
0%
Gen Y (Millennials)
Level 1 B-BBEE
Broad-Based Black Economic Empowerment contributor status in South Africa.
Arcera is present in many emerging markets and helps strengthen healthcare systems in regions that lack consistent access to reliable pharmaceuticals.
As we expand our presence to more international markets, we remain committed to addressing unmet medical needs.
We uphold international standards in all interactions with healthcare professionals and patients. Our goal is to be recognized as a trusted partner for pharmaceutical and biotech companies seeking to introduce innovative therapies to new markets.
We believe that everyone deserves access to safe, quality medicines.
0m
Total estimated patient reached with essential medicines* in 2025
0+
Countries where we reach patients
0+
Medicines in our portfolio
* as defined by the World Health Organization (WHO) in its Model List of Essential Medicines
Our commitment to quality includes the recruitment and development of our people.
Our manufacturing sites and legal entities conducting GMP activities are routinely inspected and GMP certified by the respective Health Authorities.
We work closely with health authorities and actively collaborates with partners, distributors, and industry peers to facilitate the transparent exchange of safety information.
Quality is one of our major competitive advantages, and greater access to safety information strengthens our ability to protect patients and enhance the overall safety of our medicines.
0
Passed 14 Health Authority inspections in 2025
0
Passed Notified Body ISO certification audits in 2025
0
External pharmacovigilance inspections and audits in 2025, without any critical findings
Product Quality ComplaintIf you have any complaints about one of our product, please let us know and we will get back to you as soon as we can.
Note: this form is NOT for reporting adverse drug reactions (ADR). In case you experience a side effect after using one of our products, please report it to us.
PharmacovigilanceIf you experience a side effect after using any of our products, we encourage you to report it to us. Your feedback helps us maintain and improve the safety of our products.
Our business ethics principles are the foundations of how we operate and guide every internal process and external interaction with customers, suppliers, and regulators alike.
By embedding these values within our risk management, compliance, and reporting processes, we ensure that every decision supports sustainable performance and long-term value creation.
Our Code of Ethics is the cornerstone of our governance program. It guides our interactions with partners, healthcare professionals, regulators, and government officials.
Our Anti-Bribery and Anti-Corruption Policies ensure that we uphold fair business practices.
Our Conflict of Interest Policy provides clear guidance to help employees identify and declare and manage potential conflicts.
Through comprehensive compliance training, all employees learn how to navigate ethical challenges, follow declaration procedures, and understand regional and global compliance frameworks. Our annual Compliance Day reinforces the message that integrity is a collective responsibility and a key enabler of sustainable business success.
Our Speak-Up policy and platform enable employees to report suspected violations confidentially and without fear of retaliation.
Ethical conduct is not optional. Every Arcera employee is accountable for upholding our standards and acting in accordance with our corporate values.
0%
All of our operations are risk assessed for anti-bribery and anti-corruption risks.
0%
Employees have completed Anti-Bribery and Anti-Corruption training on time in 2025.
Speak UpArcera is committed to maintaining the highest ethical standards and acting in full compliance with all applicable laws and regulations. Through our online Speak-Up platform, you can raise a concern or ask a question confidentially about compliance, ethics, the environment, health and safety, social issues, governance, human rights, or related topics.
Our Privacy Policy and related frameworks govern how we collect, process, and safeguard personal data, with the EU’s General Data Protection Regulation (GDPR) serving as our global standard unless stricter local laws apply.
Our comprehensive data protection program includes:
We are committed to maintaining robust cybersecurity systems that protect the integrity of our data and the privacy of all stakeholders.